Robert Lancaster
Vascular Surgery · Boston, MANPI 1093773673
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,903 of the $6,164 with a category attached, or 63.3%. 27 manufacturers reported payments, led by Globus Medical at 24.5% of the total. Reporting peaked in 2019 at $1,833 and has fallen 62.3% since, to $692 in 2025.
Across 116 payments — averaging $53.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$2K
- Angiodynamics, Inc.$756
- Endologix LLC$638
- Medtronic$514
- Pfizer$506
- Philips North America LLC$505
- plus $2K from 21 others
Across 25 payments — averaging $3769.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$87K
- Cook Research Incorporated$7K
What the payments were for
- Travel & lodging$1,47424%
- Food & beverage$3,90363%
- Education$541%
- Other$73312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 9 | $1,510 |
| Angiodynamics, Inc. | 2 | $756 |
| Endologix LLC | 5 | $638 |
| Medtronic(2 entities) | 10 | $514 |
| Pfizer | 18 | $506 |
| Philips North America LLC | 21 | $505 |
| Veryan Medical Incorporated | 7 | $272 |
| Johnson & Johnson | 8 | $216 |
| Cardiovascular Systems Inc. | 3 | $198 |
| Silk Road Medical, Inc. | 1 | $167 |
| Lemaitre Vascular, Inc. | 4 | $141 |
| Abbott | 1 | $117 |
| Cordis US CORP. | 3 | $98 |
| Boston Scientific | 4 | $90 |
| Amgen | 3 | $72 |
| Novartis | 3 | $64 |
| Janssen Scientific Affairs, LLC | 2 | $54 |
| Smith+Nephew | 2 | $44 |
| Livanova USA, Inc. | 2 | $44 |
| Tactile Systems Technology Inc | 1 | $30 |
| AbbVie | 1 | $23 |
| Organogenesis Inc. | 1 | $22 |
| Acera Surgical, Inc. | 1 | $20 |
| Cormedix Inc. | 1 | $18 |
| Reprise Biomedical, Inc. | 1 | $18 |
| Cook Medical LLC | 1 | $15 |
| Surmodics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,164 in reported general payments places this provider in the 60th percentile of 142 vascular surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 33 | $586 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Boston
- Thomas OdonnellBoston$845K
- Anahita DuaBoston$186K
- Marc SchermerhornBoston$71K
- Edwin GravereauxBoston$61K
- Christopher KwolekBoston$55K
- Shivani KumarBoston$45K
- Richard CambriaBoston$43K
- Payam SalehiBoston$40K
- Nicholas SwerdlowBoston$33K
- Mohamad HussainBoston$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.